Results 21 to 30 of about 310,885 (317)

Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma [PDF]

open access: yesZhongguo aizheng zazhi, 2023
Background and purpose: Long non-coding RNA (lncRNA) is abnormally expressed in lung adenocarcinoma patients, and closely related to tumor occurrence, development and chemotherapy resistance.
JIA Liqing, GE Xiaolu, JIANG Lin, ZHOU Xiaoyan
doaj   +1 more source

Dermatomyositis Anteceding Lung Adenocarcinoma [PDF]

open access: yesCureus, 2020
Dermatomyositis is often presented as paraneoplastic syndrome. The diagnosis of dermatomyositis can prompt clinicians to further investigate the underlying cause, in particular malignancy. This case report illustrates the association of lung adenocarcinoma and dermatomyositis with antecedent presentation of cutaneous and musculoskeletal manifestations,
Noor Aliza Md Tarekh   +3 more
openaire   +2 more sources

GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma

open access: yesBMC Cancer, 2018
Background Lung adenocarcinoma is the most common type of lung cancer and one of the most lethal and prevalent cancers. Aberrant glycosylation was common and essential in tumorigenesis, with fucosylation as one of the most common types disrupted in ...
Xing Wei   +6 more
doaj   +1 more source

DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation

open access: yesChinese Journal of Lung Cancer, 2021
Background and objective Lung cancer is the leading cause of death worldwide, and lung adenocarcinoma is the main subtype of lung cancer. DEP domain-containing 1 (DEPDC1) has been proved to be closely related to the occurrence and development of most ...
Jian SHEN, Mengmeng XI
doaj   +1 more source

XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma

open access: yesMedicine, 2021
Abstract Background: There is evidence that DNA methylation play major roles in lung cancer. In our previously study, C3 or f21 , also referred to as XXYLT1, rs2131877 polymorphism is associated with a reduced risk of lung adenocarcinoma. So, we explored the role of XXYLT1 methylation in lung adenocarcinoma.
Zeng, Hui   +3 more
openaire   +3 more sources

Tiptoeing on Metastatic Adenocarcinoma of the Lung [PDF]

open access: yesCase Reports in Oncological Medicine, 2019
Lung cancer remains the top cause of cancer-related death in the United States. Metastases to the distal phalanges are rare. This case illustrates an interesting presentation of metastatic adenocarcinoma of the lung that was mistaken for a benign condition of the toe.
Arupreet Kochar   +5 more
openaire   +3 more sources

Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND:Long noncoding RNAs (lncRNAs) have been shown to be involved in the development and progression of lung cancer. However, the roles of lncRNAs in lung cancer are not well understood.
Gang Xu   +9 more
doaj   +1 more source

Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma

open access: yesFrontiers in Oncology, 2021
BackgroundThe Rho GTPase family with ~20 member genes play central roles in a wide variety of cellular processes and tumor cell migration and metastasis.
Hongjin Chen   +12 more
doaj   +1 more source

Lung Adenocarcinoma in a Patient with Plasmacytoma [PDF]

open access: yesCase Reports in Hematology, 2013
An increased risk of second malignancy is well recognized in patients treated for plasma cell neoplasms. However, second solid tumor is very rare in such patients. We report a case of a 68-year-old woman with plasmacytoma who developed lung adenocarcinoma.
Kazunori Nakase   +7 more
openaire   +4 more sources

Regulation of Ferroptosis in Lung Adenocarcinoma

open access: yesInternational Journal of Molecular Sciences, 2023
Lung adenocarcinoma (LUAD) is the most common lung cancers, which accounts for about 35%-40% of all lung cancer patients. Despite therapeutic advancements in recent years, the overall survival time of the LUAD patients still remain poor, especially KRAS mutant LUAD.
Wei, Xiangyun   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy